» Articles » PMID: 39329221

Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations

Overview
Publisher Wiley
Specialty Neurology
Date 2024 Sep 27
PMID 39329221
Authors
Affiliations
Soon will be listed here.
References
1.
Pot C, Oppliger R, Castillo V, Coeytaux A, Hauser C, Burkhard P . Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease. Neurology. 2005; 64(2):392-3. DOI: 10.1212/01.WNL.0000149757.47854.6F. View

2.
Venegas Perez B, Arquero Portero T, Sanchez Fernandez M, Feliz Feliz C, Del Val Fernandez J, Garcia-Ruiz P . Apomorphine-Induced Immune Hemolytic Anemia. Mov Disord Clin Pract. 2019; 4(1):145-147. PMC: 6353508. DOI: 10.1002/mdc3.12373. View

3.
Carbone F, Djamshidian A, Seppi K, Poewe W . Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations. CNS Drugs. 2019; 33(9):905-918. PMC: 6776563. DOI: 10.1007/s40263-019-00661-z. View

4.
Vayne C, Guery E, Rollin J, Baglo T, Petermann R, Gruel Y . Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia. J Clin Med. 2020; 9(7). PMC: 7408966. DOI: 10.3390/jcm9072212. View